Sara Bhatt
MD
Assistant Professor of Hematologic Oncology
👥Biography 个人简介
Sara Bhatt investigates pharmacogenomics of immunomodulatory drugs including thalidomide, lenalidomide, and pomalidomide in multiple myeloma. Her research has characterized CRBN gene variants and expression patterns that predict response to IMiD therapy. She has identified germline and somatic pharmacogenomic determinants of both efficacy and adverse effects in myeloma patients. Her work provides insights into how pharmacogenomic profiling can optimize the use of backbone therapies in myeloma treatment protocols.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Sara Bhatt 的研究动态
Follow Sara Bhatt's research updates
留下邮箱，当我们发布与 Sara Bhatt（University of Miami Sylvester Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment